megasddw-blog

[megasddw-blog]

Medical Oxygen Concentrators Market Covering Growth Inclinations & Development Strategies until 2023

The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 million in 2018 and is projected to grow at a CAGR of 7.8% over the forecast period.

Factors characterizing the market growth are the surging worldwide number of patients requiring long-term oxygen therapy, rising prevalence of the chronic obstructive pulmonary disease, sleep apnea, and asthma, growing demand for portable oxygen concentrators, and the presence of favorable government initiatives.

On the contrary, oxygen concentrators may fail to produce therapeutic levels of oxygen due to common problems involving the air-intake system, contaminated sieve materials, and malfunctioning sieve-control valves. Patients may suffer irritation from nasal cannula as water vapor in room air can compromise the adsorption of nitrogen in the sieve beds by entering through small leaks in the internal tubing.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7876

Competitive Analysis:

Currently, the global medical oxygen concentrators market is led by various prominent companies. The major market players are adopting several growth strategies including new product launches, strategic partnerships & collaborations, operational & geographical expansions, joint ventures (JVs), divestitures, and mergers & acquisitions (M&As) to gain competitive advantage. For instance, in April 2019, Inogen, Inc. launched One G5 portable oxygen concentrator in the US. The Inogen One G5 is superior to other portable oxygen concentrators presently available in the US homecare market, which is designed for use within the homecare setting.

Segmental Overview

The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.

By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.

On the basis of technology, the market has been divided into the continuous flow and pulse dose.

Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.

By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.

Regional Outlook

The Global Medical Oxygen Concentrators Market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.

Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.

The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.

The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Browse Full Report at https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: [phone]

Email: [email protected]

#Medical Oxygen Concentrators Market

[megasddw-blog]

Cardiovascular Information System Market 2019 Covers Global Industry Share, Size, Gross Margin, Future Trends, Demand, Business Insight by Leading Key Players Forecast till 2023

MRFR’s Detailed Study Provides Monitoring Cardiovascular Information System (CVIS) Market by Scope, Applications, Key Players, Emerging Trends, Sales, Revenue, And Market Share and Growth Rate.

Cardiovascular Information System (CVIS) Market Global Players:

Carestream Health (U.S.), Scimage Inc. (U.S.), Koninklijke Philips N.V. (The Netherlands), Cerner Corporation (U.S.),   Epic Systems Corporation (U.S.), Digisonics Inc. (U.S.), Fujifilm Holdings Corporation (Japan), LUMEDX (China), Agfa-Gevaert N.V. (Belgium), IBM Health (U.S.)

Cardiovascular Information System (CVIS) Market Global Overview:

The Global Cardiovascular Information System (CVIS) Market size is poised to reach the valuation of USD 1,343.26 million by 2025, as per the latest report by Market Research Future (MRFR). The market can grow immensely at 8.30% CAGR over the forecast period (2018-2025).

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7721

High prevalence of cardiovascular diseases (CVDs) and disorders is the primary driver of the market. As per the 2015 report by the World Health Organization (WHO), nearly 17.7 million died as a result of CVDs. This has triggered the need for advanced systems in hospitals to reduce the mortality rate. In addition, government initiatives to digitize patient data is likely to bode well for the cardiovascular information system (CVIS) market. Implementation of the electronic health records (EHR) system can make it easy for doctors and physicians to lead to faster diagnosis of diseases.

Technological developments in healthcare IT has led to the launch of CVIS platforms which can be accessed remotely. This offers scope for doctors to diagnose and prescribe accurate suggestions to patients. Recent upgrades to CVIS has made it possible for different departments in the cardiology section to share and exchange information on a single platform.

The high costs associated with CVIS which can lead to hesitation towards adoption among hospitals can pose a challenge to the market growth.

Segmentation Analysis

The cardiovascular information system (CVIS) market is segmented by component, deployment, application, and end-user.

By component, software held close to 67.9% share of the CVIS market in 2017, followed by services the second largest market and hardware the least market share. The software segment is expected to reach a valuation of USD 930.65 million by 2025 due to the software being able to provide clinical data to patients and doctors in real-time. Services, on the other hand, can aim to grow at a steady pace by the end of the forecast period due to constant maintenance and upgradation of CVIS to ensure a smooth workflow in clinics and hospitals.

By deployment, web/cloud-based held the largest market share in 2017, while the on-premise segment held second largest share. The web/cloud-based CVIS is projected grow at fastest CAGR during the forecast period due to low capital investment and scalability of operations. In addition, the ease it provides in reporting information and causing minimal clinical efficiencies can lead to its adoption. On the other hand, on-premise segment accounted for the least market share due to high expenses in maintaining servers, software, and hardware.

Among applications, cardiac and peripheral catheterization held 32.4% share in 2017, followed by echocardiography, hemodynamics monitoring, electrophysiology, vascular ultrasound, nuclear cardiology, ECG/stress/Holter management, and others. Cardiac and peripheral catheterization can increase its market share by the end of the forecast period due to its extensive use in early diagnosis and treatment of congenital disorders. On the other hand, echocardiography is predicted to attain second largest share, this can be attributed to its utilization in detecting abnormal heart valves and other heart defects.

Hospitals & clinics was the biggest market end-user in 2017 with a respectable 48.2% share, followed by diagnostic laboratories, cardiac cath labs, and others. Hospitals & clinics can reach a value of USD 640 million by 2025 due to adoption of advanced diagnostic systems for treating CVDs. Diagnostic laboratories generated second largest share for the cardiovascular information system (CVIS) market by 2025. This can be credited to demand by patients for rapid diagnosis solutions.

Regional Analysis

Region-wise, the Cardiovascular Information System (CVIS) Market covers the upcoming trends in Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA). The Americas accounted for 37.6% market share in 2017, followed by Europe, APAC, and MEA.

The Americas CVIS market is expected to reach a valuation of USD 481.04 million by 2025. This can be attributed to sophisticated healthcare infrastructure and adoption of latest systems for streamlining workflow in hospitals. The use of mHealth and big data for detecting CVDs at a preventive stage by clinicians is projected to augur well for the market.

Europe, on the other hand, is predicted to grow at a steady pace due to increased funding by governments and private organizations to improve treatment facilities in cardiology departments in hospitals. Moreover, digitization of patient data is expected to be a positive indicator for the growth of the market.

TOC:

1  Report Prologue$ 1,350.00

2  Introduction$ 0.00

3  Research Methodology$ 0.00

4  Market Dynamics$ 950.00

5  Market Factor Analysis$ 950.00

6  Global Cardiovascular Information System (CVIS) Market, by Component$ 1,650.00

7  Global Cardiovascular Information System (CVIS) Market, by Deployment$ 1,650.00

8  Global Cardiovascular Information System (CVIS) Market, by Application$ 1,650.00

9  Global Cardiovascular Information System (CVIS) Market, by End User$ 1,650.00

10  Global Cardiovascular Information System (CVIS) Market, by Region$ 1,650.00

11  Company Landscape$ 1,050.00

12  Company Profiles$ 900.00

13  Appendix

Access Full Report at https://www.marketresearchfuture.com/reports/cardiovascular-information-system-market-7721

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Cardiovascular Information System Market

[megasddw-blog]

Global CBD Oil Market 2019 – Investment Strategy, Outlook and Key Development till 2023

The Global CBD Oil Market size is estimated to balloon to USD 2,177.99 million by 2023, asserts Market Research Future (MRFR). Its value stood at USD 462 million in 2018.

Legalization of marijuana and investments by firms to capitalize on the trend owing to its medical benefits are factors likely to bode well for the market. The recent approval of the 2018 Farm bill in the U.S. has been beneficial for marijuana growers. This has led to a spate of investments by firms looking to capitalize on the trend.

Rise in funding towards the medical benefits of marijuana is projected to work in favor of the CBD oil market. To this effect, the National Institutes of Health spent close to USD 140 million on cannabinoid research and development. Synthetic compounds of marijuana have been manufactured in Singapore to explore the therapeutic potential of cannabinoids.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7355

Competitive Landscape

MRFR in its report has profiled some of the key players operating in the global market for CBD Oil, which include:

CBD American Shaman

IrieCBD

Isodiol International

ENDOCA

Elixinol Global Limited

Medical Marijuana and more.

Segmental Analysis

The CBD oil market is segmented by product, application, and distribution channel.

Product-wise, marijuana-derived CBD oil led the market with 54.9% share in 2017 and followed by hemp-derived CBD oil (45.1%). The marijuana-derived oil segment can touch a value of USD 1,134.33 million, growing at a CAGR of 35.13% CAGR over the forecast period. But the hemp-derived oil segment can expand at a higher CAGR of 37.77% CAGR during the aforementioned assessment period. Factors driving this segment include stress relief, improved immunity, and strong approval by the scientific community.

By application, the neurological disorders segment is expected to exhibit 37.07% CAGR over the forecast period to accrue close to USD 348.76 million for the CBD oil market by 2023. Fibromyalgia can exhibit 36.88% CAGR during the assessment period owing to the inherent property of the oil to mitigate pain and reduce inflammation.

By distribution channel, e-commerce websites accounted for 64.2% share in 2017, followed by retail pharmacies (17.9%), medical marijuana dispensaries (9.2%), hospital pharmacies (5.3%), and others (3.4%). Retail pharmacies are expected to exhibit the highest CAGR of 36.99% during the forecast period to accrue close to USD 401.94 million by 2023. E-commerce websites, on the other hand, can generate USD 1,382.62 million by 2023. This can be attributed to the online medium being a trustworthy source for CBD oil-based products.

Regional Analysis:

Region-wise, the CBD oil market includes Americas, Europe, Asia Pacific (APAC), and Rest-of-the-World (RoW). Americas held close to 78.26% market share in 2017, followed by Europe (11.21%), APAC (9.23%), and RoW (1.30%).

The Americas are expected to sustain their position as the market leader owing to demand for several CBD oil-based products. According to the World Health Organization (WHO), close to 147 million individuals consume marijuana in the U.S. Recent legalization of marijuana which can be used in alleviating the pain of several chronic diseases is another driver in the region. Both of these factors can exponentially drive the market growth. It can generate close to USD 1,695.20 million by 2023.

The Europe CBD Oil Market size can inflate to USD 251.20 million by 2023. Legalization of marijuana in Germany and the Czech Republic is expected to bode well for regional growth. In addition, formation of companies to augur cannabis production and rising awareness of clinical applications of the compound will benefit the market.

On the other hand, the APAC region can generate close to USD 203.12 million by 2023. This can be credited to the use of marijuana for treating cases of epilepsy. According to a survey in Australia, nearly 13% of parents used illegal extracts of cannabis for treating seizures in their children. This is expected to widen the scope for CBD oil products in the region upon the passing of legalization of marijuana in the region.

Lastly, the RoW region can accrue USD 28.47 million by 2023. It can experience a tepid growth rate owing to restrictions on marijuana usage, adverse effects of cannabis, and stringent government policies.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: [phone]

Email: [email protected]

#CBD Oil Market

[megasddw-blog]

Global Cochlear Implants Market 2019 Industry Analysis, Share, Growth, Trends and Forecast 2023

Market Research Future (MRFR) Has Announced a New Release on the Global Diagnostic Imaging Services Market. The primary objective of the report is to analyze the current market landscape and its future potential.

Cochlear Implants Market Global Players:

MRFR in its report has profiled some of the top-notch companies functioning in the global cochlear implants market, which include MED-El (Austria), GAES MÉDICA (Spain), Widex (Denmark), Microson S.A. (Spain), Advanced Bionics AG (Switzerland), William Demant Holding Group (Denmark), and Cochlear Ltd (Australia).

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5256

Cochlear Implants Market Global Overview:

As per the report published by Market Research Future (MRFR), the global cochlear implants market will surpass a valuation of USD 3,200 Mn by the year 2023, reflecting an above-average CAGR of 9.89%. Cochlear implants can improve hearing capabilities. Such implants are high advanced as compared to traditional hearing aid devices. At the same time, efforts are being made to improve the quality and effectiveness of cochlear implants. Over the past couple of years, demand for cochlear implants has increase significantly. DeafandHoH.com, LLC. revealed that close 360 Mn people were suffering from moderate to severe hearing loss globally in 2014.

The number of people accepting such treatment for their hearing issues have increased considerably in recent years. The National Institute on Deafness and Other Communication Disorders stated that in the year 2013, nearly 324,200 registered devices were implanted across the globe.

The Centers of Disease Control and Prevention projected that by 2025, approximately 900 Mn people worldwide are expected to suffer from hearing loss. These is a substantial market opportunity for cochlear implants market. Factors such as rising incidence of hearing loss, increased geriatric population, increased awareness, favorable reimbursement policies and innovation in hearing implants are expected to support the market’s growth during the forecast period. Furthermore, increased government support and rising healthcare expenditure are other important factor influencing the market. Nonetheless, the high cost of implant and treatment procedures continues to hamper the market proliferation in developing countries.

The MRFR’s report also includes detailed segmental analysis of the market based on type, product, end user and region. By type, the market has been segmented into bilateral implant and unilateral implant. Based on products, the market has been segmented into accessories & upgrades and cochlear implants system. The cochlear implant system type segment currently accounts for the lion’s share of the market and expected to remain high profitable during the assessment period. By end user, the market has been segmented into ambulatory surgical centers, hospitals & clinics research & academic institutes and others.

Regions that are cover in the report include Americas, Europe, the Middle East & Africa (MEA) and Asia Pacific (APAC). The Americas currently account for the largest market share in term of value. This is primarily due to factors such as existence of a massive patient pool, advanced healthcare infrastructure, high-healthcare spending, rampant R&D efforts and strong government support. Moreover, presence of various prominent market players in the countries such as the U.S and Canada aids in placing the region at a favorable position in the global cochlear implants market. Meanwhile, Europe is likely to hold its second position in the global cochlear implants market throughout the review period. Presence of several advanced economies in Europe, especially in West Europe is a major supporting factor for the region’s market. Europe is followed by Asia Pacific, which is the third largest market for cochlear implants. Rising healthcare expenditure along with the improving caregiving services is creating opportunities for market players. The market in APAC is anticipated to exhibit a comparatively faster growth over the next couple of years. In the MEA, the market is projected to grow at a moderate pace however, increased focus on improving healthcare system is creating attractive prospects for the market in the region. The GCC countries are likely to play an important role in driving the market in MEA.

Access Full Report at https://www.marketresearchfuture.com/reports/cochlear-implants-market-5256

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Cochlear Implants Market

[megasddw-blog]

Global Diagnostic Imaging Services Market 2019 Industry Analysis, Share, Growth, Trends and Forecast 2023

The Recent Study Conducted by Market Research Future (MRFR), the Global Diagnostic Imaging Services Market will capture an impressive growth rate during the review period 2019-2023.

Top Players:

Center for Diagnostic Imaging (CDI)

Medquest Associates Inc./Novant Health

Simonmed/Dignity Health

Touchstone Imaging

Alliance Medical

Medica Group

Sonic Healthcare

Global Diagnostics

Consensys Imaging Service and more.

Diagnostic Imaging Services Market Overview:

Additionally, increasing demand for diagnostic imaging devices and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, high cost of diagnostic imaging devices and unfavorable reimbursement policies may hamper the market growth during the assessment period.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7186

Global Diagnostic Imaging Services Market is projected to grow at a CAGR of 8.2% over the forecast period. In recent years, diagnostic imaging services improved their efficiency and accuracy for the of various acute and chronic diseases including cardiovascular diseases and cancer. The increasing prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field, and the on-going technological advancements in imaging services are some factors that are anticipated to drive the market growth during the assessment period.

Regional Analysis:

On regional basis, the Americas is anticipated to dominate the global diagnostic imaging services market owing to the growing clinical R&D budgets by both government as well as public and private organizations in diagnostic imaging modalities and increasing adoption of advanced technologies in the region.  Additionally, rising prevalence of geriatric population along with various chronic diseases is contributing the growth of this market. According to a report by Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060.

Europe is expected to hold the second largest position in the global diagnostic imaging services market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Moreover, rising healthcare expenditure and awareness among people for detection of diseases is boosting the market in this region.

The Asia-Pacific region is anticipated to be fastest growing region is due to rising demand for imaging devices, good quality healthcare infrastructure and incidence of major key players for growth and development in this region.

The Middle East & Africa has the least share of the global diagnostic imaging services market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Segmentation:

The Global diagnostic imaging services market has been segmented into procedure, application, and service provider.

By procedure, the market has been segmented into X-ray, Computed Tomography, Ultrasound, MRI (Magnetic Resonance Imaging), Nuclear Imaging, Radiography and others. The procedure segment is estimated to hold major market share in the global diagnostic imaging services market due to the rising R&D activities in the medical diagnostics field.

On the basis of application, the global diagnostic imaging services market has been segmented into Neurology, Cardiology, Oncology, Musculoskeletal and others.

The Global diagnostic imaging services market, by service provider, has been segmented into Clinics & Hospitals, Diagnostic centers, Research laboratories and others.

TOC:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Diagnostic Imaging Services Market, By Procedure

Chapter 7. Global Diagnostic Imaging Services Market, By Application

Chapter 8. Global Diagnostic Imaging Services Market, By Service Provider

Chapter 9. Global Diagnostic Imaging Services Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12 MRFR Conclusion

Chapter 13. Appendix

CONTINUED…!

LIST OF TABLES:

Table 1 Global Diagnostic Imaging Services Market Synopsis, 2018–2023

Table 2 Global Diagnostic Imaging Services Market Estimates And Forecast, 2018–2023

(USD Million)

Table 3 Global Diagnostic Imaging Services Market , By Region, 2018–2023 (USD Million)

Table 4 Global Diagnostic Imaging Services Market, By Procedure, 2018–2023 (USD Million)

Table 5 Global Diagnostic Imaging Services Market, By Application, 2018–2023 (USD

Million)

Table 6 Global Diagnostic Imaging Services Market , By Service Provider, 2018–2023 (USD Million)

Table 7 North America: Diagnostic Imaging Services Market , By Procedure, 2018–2023 (USD

Million)

Table 9 North America: Diagnostic Imaging Services Market , By Application, 2018–2023

(USD Million)

Table 10 North America: Diagnostic Imaging Services Market , By Service Provider, 2018–2023 (USD

Million)

CONTINUED…!

Get Full Report at https://www.marketresearchfuture.com/reports/diagnostic-imaging-services-market-7186

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Diagnostic Imaging Services Market

[megasddw-blog]

Empty Capsule Market Report Growth, Size, Demand, Trends and Forecast 2023

Global Empty Capsule Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa.

An empty capsule is an oral dosage which resting on the manufacturing material type is available in assorted colors and sizes such as flavored capsules and pearl capsules. Capsules are available in different types such as rectal capsules, enteric coated capsules, sustained release capsules, hard gelatin capsules and soft gelatin capsules. Hard and soft capsules are the commonly used empty capsules. An empty capsule comes in assorted sizes that helps in customization and dose calibration as per the needs of the individual.

Capsules are highly favored as it is easy to swallow, have an odorless and tasteless gelatin coating that makes it palatable, causes decreased gastrointestinal irritation and have quicker dissolution times compared to other forms of oral dosage.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7153

The Global Empty Capsule Market is predicted to have a promising growth at a striking 8.8% CAGR over the forecast period (2018-2023). Capsules provide a viable substitute to tablets especially for its wide availability and easy administration. A capsule is a stable shell which is utilized to encapsulate active ingredients that are formulations possessing therapeutic activity. It is widely used in pharmaceutical industries especially when it is difficult to compress a drug in a solid tablet.

There are many factors that is driving the growth of the empty capsule market. Some of these factors as per the Market Research Future (MRFR) report include increasing use of capsule formulations amid the geriatric population, rising research and development activities and clinical trials, advancements in the capsule delivery technology, growth of pharmaceutical market, easy digestibility, easy to consume, ease of availability, rising consumer preference for capsules over tablets and surge for nutraceutical products. On the contrary, factors such as constricted regulatory guidelines laid down by the international and national regulatory authorities, lack of advanced medicinal facilities especially in under-developed nations, high initial investment, scarcity of skilled healthcare experts, prerequisite R&D, increasing raw material prices, religious and cultural issues associated to capsule consumption having animal-derived ingredients such as bovine and porcine gelatin capsule shells may hinder the growth of the empty capsule market.

Regional Analysis:

Based on region, the empty capsule market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and the Middle East and Africa. Of these, North America is anticipated to grab the largest share in the market due to high healthcare expenditure, well-developed technology and huge patient population. The empty capsule market in Asia Pacific will have the second biggest share followed by Europe. The market in the APAC region is the fastest growing due to the quickly changing healthcare sector. On the other hand, the empty capsule market in the Middle East and Africa will have minimum share due to the existence of slow and poor developing countries particularly in the African region. The market in the Middle East will have a major share owing to high spending and well-developed infrastructure.

Segmentation:

Global Empty capsule Market, by Raw Materials

Bovine

Porcine

Non-gelatin

Global Empty capsule Market, by Physical Characteristics

Halal Certification

Non-Halal Certification

Global Empty capsule Market, by Certification

Halal Certification

Non-Halal Certification

Global Empty capsule Market, by End User

Pharmaceutical Industries

Academic & Research Organizations

Global Empty capsule Market, by Key Players

Neopharma

Tabuk Pharmaceuticals

Julphar

Roxlo

QUALICAPS

ACG-Associated Capsules

Medi-Caps Ltd

Capsuge

ACDIMA

NecLife

Sunil Healthcare Limited

Arab Caps

TABLE OF CONTENT:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

CONTINUED…!

Browse Complete 90 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/empty-capsule-market-7153

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Empty Capsule Market

[megasddw-blog]

Global Nuclear Medicine Market 2019 Insights Business Opportunities, Current Trends and Restraints Forecast 2023

Global Nuclear Medicine Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa.

global nuclear medicine market will reach a valuation of USD 5.430 BN by 2023, registering approximately 6.2% CAGR throughout the forecast period (2018 to 2023).

The Global Nuclear Medicine Market has been growing rapidly, garnering colossal prominence. Significant factors contributing to the growth include the increasing prevalence of various chronic diseases such as cancer and cardiovascular & neurological diseases that are augmenting the demand for effective diagnostic procedures.

Moreover, increasing investments from public & private organizations, the rising number of diagnostic imaging centers, and the increasing preference for minimally invasive treatments, accelerate the market on the global platform.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6674

Additional factors helping the market to substantiate continually, include the rising uptake of radiopharmaceuticals and increasing R&D activities in life sciences. The geriatric population is prognosticated to generate significant demand for nuclear medicines in the future. Moreover, the spreading awareness towards nuclear medicine and its uptake in the academic medical centers, by the surgeons, and biomedical researchers propel the growth of the market.

On the other hand, factors such as the high cost of the radiopharmaceuticals and side effects associated with radiation exposure are expected to impede the growth of the market in the underdeveloped regions. Whereas, the stringent regulatory approval procedures are majorly obstructing the growth of the nuclear medicine market in the developed regions.

Key players leading the Global Nuclear Medicine Market include:

GE Healthcare

Cardinal Health

Bayer

Bracco Imaging

Lantheus Medical Imaging

Curium

Nordion Inc.

Mallinckrodt Pharmaceuticals

Advanced Accelerators Applications and more.

Global Nuclear Medicine Market – Segmentations

For ease of understanding, the MRFR analysis has been segmented into four key dynamics: -

By Product Type: Diagnostic Nuclear Medicine and Therapeutic Radiopharmaceuticals among others.

By Application: Diagnostic applications and Therapeutic applications among others.

By End-user: Hospitals & Diagnostic Centers and Research Institutes among others.

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Nuclear Medicine Market – Geographical Analysis

The North American region heading with the increasing prevalence of cancer and other chronic diseases & disorders dominates the global nuclear medicine market. The presence of several important market players is a key driving force behind the growth of the regional market. Also, factors such as the well-spread awareness towards the availability of advanced therapies and the growing geriatric population are substantiating the growth of the market.

Additionally, growing government initiatives and funding programs for research in the field, the rising demand for accurate diagnosis, alongside the awareness about the benefits of nuclear medicines are some of the factors acting as significant tailwinds for the market growth. The nuclear medicine market in the region is predominantly led by the US market which is growing rapidly due to the increasing uptake of the imaging technologies for medical training and surgeries.

Furthermore, the presence of a well-developed healthcare sector alongside the increasing biomedical research initiatives, technological advancements, and the adoption of nuclear medicine by research academics centers, and laboratories fosters the growth of the market in the region.

The nuclear medicine market in the European region accounts for the second-largest market, globally.  Factors such as the increasing number of R&D activities, new products launch, and rapid strategic initiatives such as partnerships and collaborations and are attributing to the growth of the regional market. Additionally, owing to the factors such as the availability of advanced treatment facilities, increasing healthcare expenditure, and the flourishing medical device industry is positively impacting the growth of the regional market.

The Asia Pacific nuclear medicine market has emerged as a lucrative market, globally. Factors such as the large technological advancements, proliferating healthcare sector, and ever-increasing population, especially in India and China are positively impacting the growth of the regional market.  Japan holds a substantial revenue share, whereas, China, backed by the large manufacturing base and increase in demand from the construction sector is becoming the fastest growing market in the region.

Global Nuclear Medicine Market – Competitive Analysis

Highly competitive, the nuclear medicine market appears to be fragmented owing to the presence of several large as well as small players. Strategic partnership, acquisition, expansion, product & technology launch, and collaboration remain the key strategies of market players to achieve competitive advantage.

Industry/Innovation/Related News:

April 02, 2019 --- Navidea Biopharmaceuticals, Inc. (the US), a leader in precision medicine announced that it would be presenting the results of the Company’s NAV3-21 clinical study at the Society of Nuclear Medicine & Molecular Imaging Annual Meeting in June 2019.

The presentation, titled as “A Phase I/Phase II Study of Intravenously (“IV”) Administered Tc99m Tilmanocept (“TCT”) to Determine Safety, Tolerability, Optimal Clinical Dose Selection, and Imaging Timepoint in Patients Clinically Diagnosed with Rheumatoid Arthritis (“RA”)." Besides, an abstract of the presentation will be published in the Journal of Nuclear Medicine.

April 08, 2019 --- The US - The American College of Radiology (ACR) and the Society of Nuclear Medicine & Molecular Imaging (SNMMI) announced their collaboration to create a new clinical data registry to support high-quality practice and care in nuclear medicine.

The synergistic partnership reaffirms the commitment of both organizations to provide the highest level of nuclear medicine care for our patients. The initiative will support that goal through evidence-based practice improvements born from a data-rich registry.

As part of the collaboration, SNMMI and ACR will collect and analyze data on nuclear medicine procedures and facilitate reporting of quality performance to the federal government.

The diagnostic, interventional radiology/ nuclear medicine arm of the registry will be piloted in 2019, and initially will focus on PET/CT imaging data. All sites participating in the pilot will have access to the collected data, which will include de-identified data from attending pilot institutions.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued…!

Get Full Report with Top Industry Players and Segments at https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Nuclear Medicine Market

[megasddw-blog]

Global Human Insulin Market 2019 – Investment Strategy, Outlook and Key Development till 2023

Market Research Future (MRFR) has Thoroughly Studied the Trends and Patterns in the Global Human Insulin Market. The Report offers insights into the Leading Market Players and Presents an Assessment of their Current Market Position.

The Human Insulin Market is progressing with the influence generated by growing awareness regarding well-being. Human insulin is a type of synthetic insulin that laboratories develop to mimic the insulin that is deficient in the human body. Laboratories develop these insulins by harvesting protein insulins in Escherichia coli (E-coli) bacteria. In the manufacturing process, the DNA code is placed inside the E-coli and then purified to use it commercially. The global human insulin market can anticipate a growth by 12.1% CAGR during the forecast period (2017-2023), as revealed by Market Research Future (MRFR) in a recently published report that includes segmental analysis, factors that can inspire growth in the coming years, competitive analysis of the market titans, and expert overview of the entire market.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/849

Growing cases of diabetes can be considered one of the major influencers that can provide traction to the human insulin market in the coming years. Diabetes is no longer constrained within the age-related boundaries. Changing lifestyle is also triggering a radical shift in consumption pattern which can be held responsible for increasing cases of obesity.

This can effectively push the human insulin market forward. Pen needles are also getting much recognition as they are deemed safe and effective in delivering insulin. At the same time, biosimilar drugs, all over the world, is growing popular for their cost-effectiveness. In many countries, favorable reimbursement policies are also promoting the human insulin market significantly.

Competitive Landscape:

Noteworthy companies to impact the human insulin market with strategical developments and revenue are ADOCIA, Merck & Co, Julphar, Biocon Ltd, Tonghua Dongbao Pharmaceuticals Co., Ltd., Pfizer, Inc, Bristol-Myers Squibb Company, Oramed Pharmaceuticals, Inc, Novo Nordisk A/S, GlaxoSmithKline, and Sanofi.

FDA is planning on developing new norms where it will stop regulating specific biologics like insulin and human growth hormone as drugs. This can influence the approvals of interchangeable insulin drugs which can be then substituted for branded insulin.

In 2018, FDA approved the formulation of insulin lispro, which is a rapid-acting human insulin analog and is better for glycemic control in both adults and children of 3 years and above.

Segmentation:

MRFR, in their latest report on the human insulin market, segmented it by type, methods, indication, and end-users for a better understanding of the market.

Based on the type, the human insulin market can be segmented into accessories and devices. Among the devices, pens can anticipate a surge in the market share due to its ease of application.

Based on the methods, the human insulin market includes traditional human insulin and modern human insulin. Biosimilar drugs are getting recognition which can promote the modern human insulin.

Indication-wise, the human insulin market comprises type 1 diabetes and type 2 diabetes. Type 2 diabetes segment has a considerable market share.

Based on end-users, the human insulin market consists hospitals, research centers, forensic laboratories, and others. Research centers are experiencing a surge in funding from the pharmaceutical companies which can ensure their prospect in the coming years.

Regional Analysis:

The global human insulin market, in the report published by MRFR, namely enlists the Americas, Europe, Asia Pacific (APAC), and the Rest-of-the-World (RoW).

The Americas hold the maximum market share due to substantial awareness in the region regarding diabetes. The robust healthcare and research infrastructures are providing scope for innovations which are helping various major companies in investing in the region, and high disposable income that is prevalent in the region is allowing people to avail the latest models which are spurring the human insulin market considerably.

Europe’s market is getting driven mainly by Germany where the government is pushing laboratories and research institutes for further researches. This can ensure safe growth for the market in the coming years. The APAC region, with its huge population, is projecting luring scope for growth. Human insulin market in India and China are showing great growth opportunities. Many companies are now planning to explore the region as a possible base for expansion which can give rise to the regional market.

Access Full Report at https://www.marketresearchfuture.com/reports/human-insulin-market-one-849

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Human Insulin Market

[megasddw-blog]

Global Microfluidics Device Market 2019 Industry Analysis, Share, Growth, Trends and Forecast 2023

The Microfluidics Device Market is growing steadily and has a bright future. The Market for Healthcare Industry is Growth with Top Industry Players.

The Microfluidics Devices Market is growing continually due to the vital role these devices play in the integration, miniaturization, and parallelization of various tests in the fields of diagnostics, drug development, and biological research. Moreover, widely accepted microfluidic technology that has several applications is escalating the market on the global platform, allowing integration of many medical tests on a single chip.

Acknowledging the phenomenal accruals, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global microfluidic device market will touch a phenomenal valuation by 2024, registering a strong CAGR throughout the forecast period (2016-2024).

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/684

The increasing prevalence of chronic diseases such as heart-related diseases and as cancer is prompting the demand for new drugs. Owing to their efficacy, microfluidics devices are increasingly becoming popular and are garnering tremendous traction across the life science and pharmaceutical sector.

As a result, the microfluidic device market is increasing over the past couple of years, accounting for a significant market share, worldwide. Large advancements in technology and the vast uptake of these advanced technologies drive the growth of the microfluidics device market on the global platform.

Additional factors propelling the market growth include the significant increase in the pharma sector and the increasing prevalence of chronic and lifestyle-related diseases that require routine vital statistics analysis, fueling the demand for microfluidics devices.

Also, the rise in the commercial and analytical application of these devices and use of microfluidic products for miniaturization of the chip are some of the factors that are driving the growth of the microfluidic devices market.

On the flip side, factors such as the stringent regulatory requirements to decelerate growth and geometrical and surface chemistry issues are obstructing the growth of the market. Nevertheless, factors such as the growing R&D investment in life sciences, pharmaceuticals, increase in the demand and uptake of the point of care testing, as an effective method for delivery of treatment, are expected to support the market growth during the forecast period.

Major Players:

Key players leading the global microfluidic device market include Abbott Laboratories, Siemens Healthcare GMBH, F Hoffmann-La Roche AG, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc, Fluidigm Corporation, Dolomite Centre, Raindance Technologies, Inc., Cepheid, Micronit Microfluidics, Johnson & Johnson, and Becton, Dickinson & Company among others.

Industry/ Innovation/ Related News:

February 21, 2019 --- Center for Bio-Integrated Electronics of Northwestern University (the US), presented examples of the diverse, novel classes of biocompatible electronic, and microfluidic systems with skin-like physical properties that stem from its research work in materials science, mechanical engineering, electrical engineering, and advanced manufacturing.

The study was about the University’s researchers explored soft materials for conformal electronics, nanophotonic structures, microfluidic devices and MEMS, all with an emphasis on bio-inspired and bio-integrated technologies.

February 07, 2019 --- Lunaphore Technologies S.A. (Switzerland), a leading global medtech firm developing innovative next-generation equipment for cancer research and tissue diagnostics launched its first product, LabSat TM for research applications.

The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange) is now released for commercialization.

Global Microfluidics Device Market – Segments

For enhanced understanding, the report has been segmented into four key dynamics.

By Application: Pharmaceutical, Drug Delivery, Analytical Device, Life Science Research, Environmental & Industrial, and others.

By Industry: Microfluidics and Microfluidic Devices, among others.

By Material: Glass, Polymer, and Silicon.

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Microfluidics Device Market – Regional Analysis

The North American region, heading with its one of the world's best medical facilities accounts for the leading position in the global microfluidics devices market followed by the European and Asia Pacific region, respectively.  The US, backed by the huge technological advancements and high per capita healthcare expenditures leads the microfluidics devices market in North America.

Undoubtedly, the availability of technologically advanced medical devices is positively impacting market growth.  Furthermore, the presence of well-established healthcare infrastructure and skilled professionals is pushing up the regional market.

The European region owns the next largest share in the global microfluidic device market, following the North American market closely.  Factors propelling the growth of the regional market include the resurging economy that is availing the best possible healthcare & substantially high healthcare expenditures and the government support that encourages manufacturers of microfluidics devices to develop new and better devices.

The Asia Pacific region is emerging as a profitable market for microfluidics devices due to the rapidly improving healthcare infrastructure. Moreover, factors such as the ever-increasing population that is continually dictating the demand for quality healthcare and the spreading awareness towards the availability and benefits of these devices are positively impacting the growth in the regional market. Rapidly developing economies are expected to provide immense opportunities for the growth of microfluidics devices.

Also, the increasing adoption of technologies is positively impacting market growth in the region. Furthermore, rising healthcare concerns are leading to increasing the market size of the microfluidic device market.

Global Microfluidics Device Market – Competitive Analysis

Highly competitive, the microfluidics market appears to be fragmented owing to the presence of several large and small-scale players. These players invest substantially in R&D to develop advanced sensors. High potential growth opportunities that the market demonstrates are in turn, attracting several new entrants to the market, further intensifying the competition in the already fiercely competitive market.

Well-established players incorporate strategic initiatives such as acquisition, collaboration, expansion, partnership, and product & technology launch in order to gain a competitive advantage in this market and to maintain their market positions.

Prominent manufacturers of microfluidics invest substantially in technology and R&D activities and most of all, in acquiring other promising firms in the rapidly growing regions to meet their expansion plan. The rising government fundings are motivating key companies to manufacture new devices that can match the changing trends and needs of the customers.

Browse Complete 110 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/microfluidics-device-market-684

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Microfluidics Device Market

[megasddw-blog]

Medical Digital Imaging Devices Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2023

MRFR offers a Phenomenal Analysis of Global Microfluidics Devices Market by Segmentation, Regional Analysis, Top Companies, Scope, and Applications. Covering North America, Europe, Asia Pacific, Middle East and Africa.

Top Players:

Some of the prominent players in the global medical digital imaging devices market are Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Esaote SPA, Canon Medical Systems Corporation, Hologic, Hitachi, and Shimadzu.

Market Overview:

The Global Medical Digital Imaging Devices Market held a market value of USD 12.9 Billion in 2017 and is projected to grow at a CAGR of 7.1% over the forecast period. Medical digital imaging devices are digital devices that are used to image the body to obtain a correct diagnosis and determine future care.

Segmentation:

The Global Medical Digital Imaging Devices Market has been segmented into component, deployment model, functionality, and end user.

By type, the market has been segmented into x-ray, computed tomography, ultrasound, MRI, and nuclear imaging. The x-ray segment is expected to register the highest CAGR during the forecast period due to technological advancements.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7880

On the basis of technology, the market has been segmented into 2D, B/W, Color, and 3D/4D.

The market, by end user, has been segmented into hospitals and clinics, diagnostic centers, and others.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global medical digital imaging devices market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and a large number of diagnostic imaging centers. Additionally, fast adoption of technologically advanced imaging systems and increasing awareness of the benefits of early diagnosis of diseases is driving the growth of the market.

Europe accounts for the second largest market and holds a healthy share in the global medical digital imaging devices market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing medical device industry due to the presence of major market players.

Asia-Pacific is expected to be the fastest growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.

Table Of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5. Market Factor Analysis

Continued...

Access Full Report at https://www.marketresearchfuture.com/reports/medical-digital-imaging-devices-market-7880

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Medical Digital Imaging Devices Market

[megasddw-blog]

Global Intraocular Lens Market 2019 Business Insights & Deep Analysis to 2023 by World’s Top 10 Key Players

Market Research Future (MRFR) Conducted an Elaborate Study on the Global Intraocular Lens that predicts the Growth of the market with Top Players during the forecast period of 2019-2023.

It is estimated that the global intraocular lens market is expected to register a CAGR of ~ 5.43% during the forecast period of 2018–2023 with an estimated market value of USD 3.54 billion in 2017. Intraocular lens is implanted inside the eye substituting the eye’s natural lens. These lenses are very effective in nature and are used for the correction of numerous eye defects such as astigmatism, presbyopia, near-sightedness (myopia), and among others.

The rising prevalence of eye diseases, and high rate of adoption of premium intraocular lens technology is expected to drive the growth of the market extensively. Also, increase in the geriatric population and the rise in diabetic population is estimated to drive the growth of the intraocular lens market. According to the data published in 2015 by the Centers for Disease Control and Prevention (CDC), Refractive errors are the most frequent eye problems in the US. Also, according to the report published in 2016 by National Eye Institute, proper refractive eye correction could improve vision among 11 million Americans aged 12 years and older.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7264

Factors such as post-operative complications, high cost of intraocular lens, and lack of skilled medical professionals are restraining the growth of market. Also, lack of reimbursement policies for premium lens in many developing and underdeveloped regions is anticipated to hinder the growth of the intraocular market.

The global intraocular lens market is currently dominated by many market players. The key players in the market are involved in strategic collaborations and new product launches to brace its market position. For instance, in December 2018, Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., received 510(k) clearance from the US Food and Drug Administration (FDA) for Bausch + Lomb ULTRA Multifocal for Astigmatic correction. Thus, the company broadened its product portfolio to hold its position in the market.

Top Companies:

Alcon Inc.

Bausch + Lomb

Eyekon Medical Inc.

Humanoptics AG

Lenstec Inc.

Oculentis GmbH

PhysIOL

STAAR Surgical Company and others.

Regional Analysis:

The market in the Americas is expected to dominate the global intraocular lens market during the forecast period owing to the rising healthcare expenditure. In addition, proactive government initiatives to spread awareness about the benefits of intraocular lens among the masses have supplemented the market growth. Europe is expected to hold the second largest position in the global intraocular lens market. The market growth in this region is attributed to the existence of a well-established healthcare system and increase in insurance coverage. Asia-Pacific is estimated to be the fastest growing region in the market due to the improving healthcare infrastructure. The market in the Middle East & Africa is likely to account for the smallest share of the global intraocular lens market.

Segmentation:

The global intraocular lens market has been segmented into type, material and end user. The market, based on type, has been segmented into monofocal intraocular lens, multifocal intraocular lens, accommodating intraocular lens, phakic intraocular lens, and others.

The market, by material, has been segmented into hydrophobic acrylic, hydrophilic acrylic, polymethylmeth-acrylate (PMMA), and others.

The market, by end user has been segmented into hospitals, ophthalmic clinics, ambulatory surgical centers, and others.

Get Full Reports with Niche Segments and Top Players at https://www.marketresearchfuture.com/reports/intraocular-lens-market-7264

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#ntraocular Lens Market

[megasddw-blog]

Orthobiologics Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2023

MRFR offers a Phenomenal Analysis of Global Orthobiologics Market by Segmentation, Regional Analysis, Top Companies, Scope, and Applications. Covering North America, Europe, Asia Pacific, Middle East and Africa. And It Is Incorporated On Marketresearchfuture.Com With 128 Pages.

Orthobiologics are derived from the human body and used by surgeons for treating injuries. It helps in easy recovery and healing of wounds. It can be useful for treating broken bones and injured muscles, tendons, and ligaments. The surge in cases of trauma and sports injury, rising demand for biologics in minimally invasive procedures, increasing product approvals, and raising awareness are expected to drive the growth of the global orthobiologics market during the forecast period.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7826

Moreover, emerging technological inventions in biomaterials, growing obese and geriatric population, and increasing research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market. According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, 5.1% of men of 65 years and over are suffering from the lumbar spine in the US. Also, 24.5% of women 65 years of age and over have a lumbar spine in US.

The high costs associated with the orthobiologics, absence of proper reimbursement policies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.

Major Players:

Some of the key players in the global orthobiologics market are Arthrex, Inc., Exactech, Inc., Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries, Inc., NuVasive, Inc., Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet, and Others

Segmentations

The global orthobiologics market has been segmented on the basis of product, application, end-user, and region.

Based on product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.

Global orthobiologics market on the basis of application has been segmented into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others.

Based on end-user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.

Regional Analysis:

The market is likely to dominate by Americas during the forecast period owing to the well-established healthcare infrastructure, rising incidences of spinal disorders, obese and geriatric population, and preference for minimally invasive procedures.

Europe is expected to be the second-largest market in the global orthobiologics market due to the rising adoption of newly introduced treatment procedures and technologies by a physician and patient awareness, government funding and support of the healthcare sector.

The Asia-Pacific market is likely to hold a significant market share in the orthobiologics market. The rising demand for advanced treatment, awareness and increasing investment in healthcare are responsible for the growth of this market in the region.

The market in the Middle East & Africa is expected to account for the smallest share of the global orthobiologics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Browse Full Report at https://www.marketresearchfuture.com/reports/orthobiologics-market-7826

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Orthobiologics Market

[megasddw-blog]

Ophthalmic Lasers Market 2019 Size, Business Research, Revenue, Growth Insights to 2023

Market Research Future has published a new report titled as “Global Ophthalmic Lasers Market” the report offer detailed insights about the Historical Trends and Current Scenario with Top Industry Players, Major Drivers and Industry Dynamics up to 2023.

The Global Ophthalmic Lasers Market accounted for USD 1,050 million in 2017 and expected to register CAGR ~4.6% during the forecast period of 2018 to 2023.

Ophthalmology is a branch of medicine which deals with the diagnosis, treatment, and prevention of diseases related to eye and vision. Ophthalmic disorders are increasing day by day due to change in lifestyle and changing environmental conditions. The factors propelling the growth of the global ophthalmic lasers market are the rising prevalence of ophthalmic disorders along with the growing geriatric population, increasing number of product approvals and rising occurrences of chronic diseases such as.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6879

However, the high costs associated with ophthalmic surgical procedures, increasing cost of ophthalmic laser, and lack of skilled workforce may hamper market growth during the assessment period.

Top Players:

Some of the key players in the global ophthalmic lasers market are Alcon Laboratories, Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Quantel Inc., Abbott Medical Optics, Inc., Ellex Medical Lasers Limited, Ocular Instruments, Topcon Corporation, Iridex Corporation, Nidek Co., Limited, Lightmed USA, Ziemer Ophthalmic Systems AG, and Lumenis Ltd.

Regional Analysis:

In the Americas, the North American market is likely to hold the majority share of the ophthalmic lasers market owing to the increasing number of patients suffering from ophthalmic disorders or problems related to vision, the rising prevalence of chronic diseases, technological advancement in the region, and growing geriatric population. According to the American Diabetes Association, in 2015, approximately 30.3 million Americans had diabetes, and the burden of diabetes on healthcare in 2017 was USD 327 billion. The US is expected to account for the largest share of the North American market during the forecast period owing to the presence of major market players such as Abbott Medical Optics, Inc., Lightmed USA, Bausch & Lomb Incorporated, and Ocular Instruments.

The global ophthalmic lasers market is currently dominated by several players. The market players are engaged in strategic collaborations and acquisitions to expand their product portfolios. For instance, in February 2017, Johnson & Johnson acquired Abbott Medical Optics for approximately USD 4,325 million, this acquisition will help Johnson & Johnson to gain control over cataract surgery, laser refractive surgery, and consumers’ eye health.

The global ophthalmic lasers market has been segmented on the basis of product, application, and end-user.

Toc:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1Research Objective

2.2.2Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued...

Access Full Report at https://www.marketresearchfuture.com/reports/ophthalmic-lasers-market-6879

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Ophthalmic Lasers Market

[megasddw-blog]

Ophthalmic Lasers Market 2019 Global Trend, Segmentation and Opportunities - Forecast to 2023

Market Research Future has published a new report titled as “Global Ophthalmic Lasers Market” the report offer detailed insights about the Historical Trends and Current Scenario with Top Industry Players, Major Drivers and Industry Dynamics up to 2023.

The Global Ophthalmic Lasers Market accounted for USD 1,050 million in 2017 and expected to register CAGR ~4.6% during the forecast period of 2018 to 2023.

Ophthalmology is a branch of medicine which deals with the diagnosis, treatment, and prevention of diseases related to eye and vision. Ophthalmic disorders are increasing day by day due to change in lifestyle and changing environmental conditions. The factors propelling the growth of the global ophthalmic lasers market are the rising prevalence of ophthalmic disorders along with the growing geriatric population, increasing number of product approvals and rising occurrences of chronic diseases such as.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6879

However, the high costs associated with ophthalmic surgical procedures, increasing cost of ophthalmic laser, and lack of skilled workforce may hamper market growth during the assessment period.

Top Players:

Some of the key players in the global ophthalmic lasers market are Alcon Laboratories, Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Quantel Inc., Abbott Medical Optics, Inc., Ellex Medical Lasers Limited, Ocular Instruments, Topcon Corporation, Iridex Corporation, Nidek Co., Limited, Lightmed USA, Ziemer Ophthalmic Systems AG, and Lumenis Ltd.

Regional Analysis:

In the Americas, the North American market is likely to hold the majority share of the ophthalmic lasers market owing to the increasing number of patients suffering from ophthalmic disorders or problems related to vision, the rising prevalence of chronic diseases, technological advancement in the region, and growing geriatric population. According to the American Diabetes Association, in 2015, approximately 30.3 million Americans had diabetes, and the burden of diabetes on healthcare in 2017 was USD 327 billion. The US is expected to account for the largest share of the North American market during the forecast period owing to the presence of major market players such as Abbott Medical Optics, Inc., Lightmed USA, Bausch & Lomb Incorporated, and Ocular Instruments.

The global ophthalmic lasers market is currently dominated by several players. The market players are engaged in strategic collaborations and acquisitions to expand their product portfolios. For instance, in February 2017, Johnson & Johnson acquired Abbott Medical Optics for approximately USD 4,325 million, this acquisition will help Johnson & Johnson to gain control over cataract surgery, laser refractive surgery, and consumers’ eye health.

The global ophthalmic lasers market has been segmented on the basis of product, application, and end-user.

Toc:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1Research Objective

2.2.2Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued...

Access Full Report at https://www.marketresearchfuture.com/reports/ophthalmic-lasers-market-6879

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Ophthalmic Lasers Market

[megasddw-blog]

Dietary Supplements in the age of Personalized Nutrition Market 2019 Covers Global Industry Share, Size, Gross Margin, Future Trends, Demand, Business Insight by Leading Key Players Forecast till 2023

MRFR’s Detailed Study Provides Monitoring Dietary Supplements in the age of Personalized Nutrition Market by Scope, Applications, Products, Key Players, Emerging Trends, Sales, Revenue, And Market Share and Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa.

In recent years, the dietary supplement market has witnessed tremendous growth. The major factors influencing the growth of the market include rapid diversification and rising prevalence of various lifestyle diseases worldwide, rising approval from government bodies, growing awareness, and screening for diabetes mellitus, rise in research funding for diagnosis and treatment of these conditions. Furthermore, increasing government healthcare expenditure for the welfare of the population, has spurred the growth of this market.

Healthcare expenditure across the globe is continuously increasing. From the last decades, healthcare expenditure in regions like the Americas and Europe has increased. According to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending is likely to increase 5.8% reaching USD 3.2 trillion. Since 2016, the healthcare spending in North America has been increased. Canadian healthcare specifically was stressed by an advancing demographic move. Therefore, growing healthcare expenditure.

Increasing incidence of diseases due to sedentary lifestyle and a lack of balanced diet has majorly influenced the growth of the market. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5703

According to the same study, it was found that 82% of the total deaths occurred in the low and middle-income countries. Dietary supplements in the age of personalized nutrition plays an important role in the treatment of various lifestyle diseases such as atherosclerosis, cardiovascular disease, stroke; obesity and type 2 diabetes due to which there has been an increasing demand for dietary supplements in the age of personalized nutrition. Changing the dietary approaches and switching to therapeutic lifestyle prove effective in the prevention of hypertension and other cardiovascular disorders. Furthermore, many organizations such as the America Heart Association and the National Heart, Lung and Blood Institute have come up with strategic diets to minimize the risks for cardiovascular and other lifestyle related diseases.

Market Segmentation:

The Global Dietary Supplements in the Age of Personalized Nutrition Market are segmented on the basis of product category, application, gender, dosage form and end user.

On the basis the product category, it is segmented into vitamins, herbs & botanicals, sports supplements, meal supplements, minerals and other.

On the basis of the application, it is segmented into lifestyle diseases, inherited diseases, genetic predispositions and others.

On the basis of the gender, it is segmented into female and male. Female and male is further segmented into various age groups, namely, 55 + age group, 35-54 age group, 19-34 age group, and 0-18 age group.

On the basis of the dosage form, it is segmented into tablets, capsules, powder, liquids, soft gels and others.

On the basis of the end users, it is segmented into hospitals & clinics, home care, and others.

Top Players:

Nestlé Health Science

Danone Nutricia

Carlyle Group

Amway

Archer Daniels Midland

Abbott Laboratories

Herbalife International

Amway

Danisco, etc.

Regional Analysis:

Global dietary supplements in the age of personalized nutrition market, on the basis of region is divided into the Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas accounted for the largest market share of 35.3% In 2016 for global dietary supplements in the age of personalized nutrition market. This large share is majorly attributed due to presence of major manufacturers, high consumption of dietary supplements, rising awareness towards weight management, and various others. Europe account for the second largest market share, whereas Asia Pacific is expected to grow at the fastest rate with 7.55% CAGR for the forecast period. With lots of opportunity and continuously growing economies, the region is expected to be the fastest growing segment. Factors such as recent healthcare developments, improving economies, high aging population, and increased healthcare spending are influencing the growth of the market. The Middle East & Africa with less economic developments and extremely low income accounted for the least market share in 2016 but is expected to grow in coming future.

TOC:

1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Dietary Supplements in an Age of Personalized Nutrition Market, By Product Category

7 Global Dietary Supplements in the Age of Personalized Nutrition Market, By Application

8 Global Dietary Supplements in the Age of Personalized Nutrition Market, By Gender

9 Global Dietary Supplements in the Age of Personalized Nutrition Market, By Dosage Form

10 Global Dietary Supplements in the Age of Personalized Nutrition Market, By End user

11 Global Dietary Supplements in the Age of Personalized Nutrition Market, By Region

12 Company Landscape

13 Company Profiles

14 Conclusion

15 Appendix

Access Full Report at https://www.marketresearchfuture.com/reports/global-dietary-supplements-market-5703

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Dietary Supplements in the age of Personalized Nutrition Market

[megasddw-blog]

Clinical Laboratory Test Market Covering Growth Inclinations & Development Strategies until 2023

The Report of “North America Clinical Laboratory Test Market” Research Future Covers the Information like Market, Prominent Players and North America Clinical Laboratory Test Market Segmentation, Regional Outlook, End-User and Forecast to 2023.

North America Clinical Laboratory Test Market is growing at a steady pace; where the growth is mainly due to increasing prevalence of chronic diseases, increased patient population, increase in volume of in-vitro diagnostic tests, current reimbursement scenario, and increasing patient awareness about the clinical test.

Clinical laboratory testing has emerged as the most growing segment of healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood test, anatomical pathological testing, molecular, immunological, drug testing and other tests for disease diagnosis and treatment.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2249

Segments:

The North America clinical laboratory test market is majorly segmented on the basis of type of laboratory, type of test, and by country. Based on the type of laboratory, the market is segmented into hospital based laboratory, central/ independent laboratory, physician office laboratory, and others. Based on type of test these are classified into CBC and other routine test, anatomic pathology, molecular test, immunology test, drug test and others. Further on the basis of country the market is classified into U.S., Canada, and Rest of North America.

Key Players:

The North America market consist of players such as  AURORA Diagnostics (U.S.), Laboratory Corporation of America (U.S.), LifeLabs Medical Laboratories (Canada), Quest Diagnostics (U.S.), Sonic Healthcare (Australia) are some of the prominent players at the forefront of competition in the North America Clinical Laboratory Test Market and are profiled in MRFR Analysis report.

North America Clinical Laboratory Test Market - Regional Analysis:

US accounts for the maximum market share of North America Clinical Laboratory testing market and is expected to grow at a CAGR of 5.8% during the forecasted period. Maximum number of laboratories and clinical testing procedures are the major reason for the highest market growth of this region. Canada, is expected to be the fastest growing region with the CAGR of 6.3% during the forecasted period due to increasing cases of chronic disease and also because of new companies providing laboratory services entering Canadian market.

North America Clinical Laboratory Test Market   - Competitive Analysis

Quest diagnostics and Laboratory Corporation of America Holdings are the two biggest companies of the North America clinical laboratory testing market. Certainly, both the companies offer a wide range of diagnostic testing services, right from routine CBC testing to prenatal tests, and further to highly sensitive cancer and genetics tests.

Globally, Quest diagnostics is the largest independent research and testing lab, and commands around 17-18% share of the total market. LabCorp follows Quest and accounting for around 10-12% market share of the domestic market, but is growing at a faster pace than its main rival.

Merger & acquisitions with other companies and other small players was the key strategy adopted by the major players.

Major TOC of North America Clinical Laboratory Test Market Research Report - Forecast to 2022:

1 Report Prologue

2 Market Dynamics

3 Market Factor Analysis

4 North America Clinical Laboratory Test Market, By Type of Laboratory

5 North America Clinical Laboratory Test Market, By Type of Test

6 North America Clinical Laboratory Test Market, By Country

7 North America Clinical Laboratory Test Market: Competitive Landscape

8 Company Profile

Browse Complete 85 Pages Premium Research Report Enabled with 10+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/america-clinical-laboratory-test-market-2249

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Clinical Laboratory Test Market

[megasddw-blog]

Radiopharmaceutical Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2023

The Report of “Radiopharmaceutical Market” Research Future Covers the Information like Market, Prominent Players and Radiopharmaceutical Market Market Segmentation, Regional Outlook, End-User and Forecast to 2023.

Radiopharmaceuticals are radioisotopes used for the therapeutic and diagnosis purposes and play a crucial role in the medical diagnosis. Radiopharmaceutical can be used with imaging devices to study the dynamic processes taking place in various parts of the body. The global radiopharmaceutical market likely to attain USD 10,473.88 Mn at a CAGR of 8.7% over the forecast period of 2017-2023. The key factors influencing the growth of the global radiopharmaceutical market include the massive shift of the healthcare industry towards a personalized approach towards diagnosis and treatment.

Widespread prevalence of chronic diseases such as cancer, cardiovascular diseases and others have generated huge demand for treatment and diagnosis which has provided an impetus to the growth of the market. In addition, growing incidence rate of oncology diseases creates the need for cancer management which is anticipated to be plus for the growth of the global radiopharmaceutical market. On the other hand, risks associated with radiopharmaceuticals are expected to e hurdle to the growth of the global radiopharmaceutical market. Low feasibility of treatment and high costs of devices might also impede the growth of the market over the forecast period.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1650

Competitive Landscape

The key players in the global radiopharmaceutical market include Medtronic, Canadian Nuclear Laboratories (CNL), Jubilant Life Sciences Ltd., Lantheus Medical Imaging, Inc., Bayer AG, Advanced Accelerator Applications S.A., Bracco Diagnostic Inc., Mallinckrodt Pharmaceuticals, General Electric Company (GE Healthcare), Cardinal Health Inc., IBA Dosimetry GmbH, Siemens AG, Nordion, Inc., Sun Pharmaceutical Industries Ltd., and Avid  Radiopharmaceuticals.

Industry Updates

In January 2019, RadioMedix Inc., a biotechnology company focused on targeted radiopharmaceuticals and Curium, a leader in radiopharmaceuticals, announced that FDA has granted Fast Track designation to their diagnostic radiopharmaceutical, 64Cu-Dotatate.

Segmentation

The global radiopharmaceutical market has been segmented based on type, type of test, application, route of administration, and end user.

By type, the global radiopharmaceutical market has been segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. The diagnostic type radiopharmaceutical segment has been further segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. The SPECT radiopharmaceutical sub segment has been further segmented into Technetium-99m, Thallium-201, Iodine-123, and others. The PET radiopharmaceutical sub segment has been further segmented into  F-18, Rubidium-82, and others.

The therapeutic type radiopharmaceutical segment has been further segmented into beta emitters, alpha emitters, brachytherapy. The beta emmiters sub-segment has been further segmented into Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177, and others. The brachytherapy sub segment has been further segmented into Iodine-125, Iridium-192, Cesium-131, and others.

By type of test, the global radiopharmaceutical market has been segmented into bone scan, white blood cell scan, myocardial perfusion scan, lung scan, parathyroid scans, hepatobiliary scans, gallium scan, renal nuclear medicine scan, cerebral perfusion scan and others. The bone scan segment has been further segmented into Technetium-99m 1st, fluoride-18 2nd, and others. The Myocardial Perfusion Scan segment has been further segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan segment has been further segmented into Xenon-133, Krypton-81m, and others. The white blood cell scan segment has been further segmented into Indium-111 and others.

By application, the global radiopharmaceutical market has been segmented into oncology, cardiology, neurology, urology, and others. The oncology segment has been further segmented into prostate cancer, bone cancer, breast cancer and others. The cardiology segment has been further segmented into coronary artery disease, cardiomyopathy and others. The neurology segment has been further segmented into traumatic brain injury, stroke, Alzheimer’s disease and others. The urology segment has been further segmented into acute pyelonephritis, congenital renal anomalies, and others.

By route of administration, the global radiopharmaceutical market has been segmented into oral, intravenous and others.

By end user, the global radiopharmaceutical market has been segmented into hospitals, diagnostic centres, research institutes and others.

Regional Analysis

By region, the global radiopharmaceutical market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas and Europe collectively account for the foremost share of the global market. High healthcare expenditure, robust healthcare sector and prevalence of chronic diseases in these regions such as cancer, coronary disorders, stroke among others are driving the market in theses region. High investment in R&D activities and presence of huge patient pool and market players augur the growth of these markets. The Americas is the larges market while Europe follows the Americas closely. APAC is poised to be the fastest growing market for radiopharmaceuticals. Expanding patient population base, surging prevalence of chronic diseases stimulate the growth of the market. High healthcare spending in the emerging economies of the region coupled with rising awareness which generate huge demand for diagnostics has fueled the growth of the market in the region.

Access Full Report at https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

[phone]

Email: [email protected]

#Radiopharmaceutical Market